FIELD: medicine, narcology. SUBSTANCE: method involves the use of lupeptine. EFFECT: enhanced effectiveness of abstinent syndrome arresting at opiomania. 2 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR ARRESTING AN ABSTINENT SYNDROME AT OPIOMANIA | 1996 |
|
RU2116084C1 |
ANALGETIC PREPARATION | 1992 |
|
RU2077326C1 |
PREPARATION FOR TREATING OPIUM NARCOMANIA | 2001 |
|
RU2201761C1 |
ANALGETIC PREPARATION | 1992 |
|
RU2083202C1 |
MEANS FOR OPIOID ABSTINENCE SYNDROME ARRESTING | 2017 |
|
RU2643588C1 |
AGENT USED IN PROPHYLAXIS AND TREATMENT OF OPIOMANIA | 2002 |
|
RU2264228C2 |
IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
COMPOSITION FOR TERMINATION OF OPIATE ABSTINENT SYNDROME MANIFESTATIONS | 2007 |
|
RU2323725C1 |
MEDICATION FOR WITHDRAWAL SYNDROME MANAGEMENT IN OPIATE DEPENDENCE | 2012 |
|
RU2485954C1 |
MEDICAL PREPARATION FOR TREATING NARCOMANIA | 1999 |
|
RU2159615C1 |
Authors
Dates
1997-07-10—Published
1993-03-30—Filed